Methylphenidate Patient Tips
Medically reviewed on Jul 28, 2017 by C. Fookes, BPharm.
How it works
- Experts aren't exactly sure how methylphenidate works in Attention Deficit Hyperactivity Disorder (ADHD) but think it affects the reuptake of the neurotransmitters dopamine and norepinephrine, increasing their concentration in the neural synapse (the space between two nerves).
- Methylphenidate is composed of 2 enantiomers (optical isomers): d-threo and l-threo. The d-threo enantiomer is more pharmacologically active than the l-threo enantiomer and is available commercially as dexmethylphenidate.
- Methylphenidate belongs to the group of medicines known as central nervous system (CNS) stimulants.
- Methylphenidate may be used to treat attention deficit hyperactivity disorder (ADHD) in people aged 6 to 65.
- May also be given to treat attention deficit disorder (ADD) and narcolepsy.
- Methylphenidate should be used in addition to other treatment modalities such as psychotherapy, education, and social integration advice.
- Methylphenidate is available as immediate-release tablets and suspension and in an extended-release form.
- Generic methylphenidate is available.
If you are between the ages of 18 and 60, take no other medication or have no other medical conditions, side effects you are more likely to experience include:
- A headache, abdominal pain, a loss of appetite, dry mouth, a fast heartbeat, nausea, nervousness, and insomnia are commonly reported side effects. Rash, pruritus, irritability, an increase in blood pressure or excessive sweating may also occur.
- May precipitate the emergence of psychotic thoughts such as hallucinations, delusions or mania in children and adolescents without a prior history of such thoughts. Discontinuation of treatment may be appropriate.
- Methylphenidate can be addictive and cause dependence. The risk is greater with extended-release tablets and in people with a history of drug dependence and alcoholism. Tolerance can also develop to methylphenidate's effect.
- May impair judgment or reaction skills; exercise caution before driving or operating machinery until full effects of methylphenidate are known.
- May precipitate depression during withdrawal from methylphenidate, particularly in those who have been overusing it. May also aggravate pre-existing symptoms of anxiety, agitation, tension, behavioral or thought disturbances and is best avoided in people displaying marked levels of these symptoms.
- May not be suitable for people with certain heart conditions, hyperthyroidism, and other psychiatric disorders including bipolar disorder. An increased risk of seizures, peripheral circulation problems, and visual disturbances have been associated with methylphenidate use. Should not be used in people with glaucoma, a history of tics or Tourette's syndrome, severe hypertension or cardiac disease.
- Alcohol may contribute to the side effects and interfere with the release of extended-release methylphenidate. Avoid.
- May interact with a number of other drugs including monoamine oxidase inhibitors (MAO inhibitors) (do not use within 14 days of discontinuation of a MAO inhibitor), halogenated anesthetics (do not take methylphenidate on the day of surgery), warfarin, anticonvulsants, and some antidepressants.
- Reports indicate some temporary slowing of growth may occur when regular methylphenidate is given to children aged 7 through 10 years: doctors should monitor height and weight and consider treatment interruption if growth suppression is suspected.
- Has been associated with sudden death; cases were mainly in children and adults with serious structural cardiac abnormalities or other serious heart problems. Avoid in those known to have these risk factors.
- Rare cases of priapism (painful erections more than 6 hours in duration) have been reported.
- Caution when using in people with pre-existing bowel problems (includes those with severe narrowing of the intestinal tract and gut motility disorders) as extended-release tablets maintain their shape and potentially may cause a blockage. May affect blood circulation in the hands and feet. Symptoms may improve after a dosage reduction or discontinuation.
- Periodic blood tests may be required with prolonged dosing.
- Drug testing will reveal a positive result for methylphenidate.
- Classified as a Schedule II controlled substance, meaning that methylphenidate has a high potential for abuse. Keep personal supplies of methylphenidate in a safe place, out of view of potential drug seekers.
Notes: In general, seniors or children, people with certain medical conditions (such as liver or kidney problems, heart disease, diabetes, seizures) or people who take other medications are more at risk of developing a wider range of side effects. For a complete list of all side effects, click here.
- Some branded and generic versions of methylphenidate need to be taken 30 to 45 minutes before food. Ensure you know when to take your branded or generic version of methylphenidate.
- If taking multiple doses of methylphenidate, ensure that your last dose is taken before 6pm. Extended-release formulations of methylphenidate are usually taken as a single daily dose before breakfast. If you cannot swallow the extended-release capsule, it may be opened and the contents mixed with applesauce and swallowed whole.
- Take methylphenidate exactly as directed by your doctor. Do not increase the dosage unless your doctor has told you to do so.
- Swallow extended-release methylphenidate tablets or capsules whole with a glass of water. Do not chew, divide or crush or attempt to dissolve in water.
- Methylphenidate may impair your judgment or reaction skills and make driving or operating machinery difficult. Do not drive or operate machinery if methylphenidate affects you in this way.
- Avoid alcohol while you are taking methylphenidate. Alcohol may potentiate the side effects of methylphenidate and affect its absorption.
- Seek urgent medical attention if you develop any chest pain, shortness of breath or fainting occurs while taking methylphenidate. Call your doctor if you have any new or worsening mental symptoms such as hallucinations, delusions, or hearing voices.
- Seek medical advice if any new numbness, pain, skin color change or sensitivity, or unexplained wounds occur in the fingers or toes. Seek emergency attention if painful, prolonged erections develop.
- Do not be concerned if you notice something in your stool that looks like a tablet. The casing of some extended-release forms of methylphenidate does not fully dissolve.
Response and Effectiveness
- Time to peak concentrations of methylphenidate following immediate-release formulations is approximately 1.9 hours.
- Extended-release tablets or capsules have a two-phase release system. Initial peak concentrations are reached within an hour following administration, and another peak is seen approximately three hours later.
- Some relief from the symptoms of ADHD may be noticed within one to two hours of dosing; however, it may take up to two weeks for the full effects of methylphenidate to develop.
Methylphenidate [Package Insert]. Revised 05/2017. Teva Pharmaceuticals USA, Inc. https://www.drugs.com/pro/methylphenidate-cd-capsules.html
More about methylphenidate
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Compare Alternatives
- Support Group
- Pricing & Coupons
- 654 Reviews – Add your own review/rating
- Drug class: CNS stimulants
- Methylphenidate transdermal
- Methylphenidate Chewable Tablets
- Methylphenidate Controlled-Release Tablets
- Methylphenidate Extended-Release Chewable Tablets
- ... +8 more
Related treatment guides
- Remember, keep this and all other medicines out of the reach of children, never share your medicines with others, and use methylphenidate only for the indication prescribed.
- Disclaimer: Every effort has been made to ensure that this information is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This drug information does not endorse drugs, diagnose patients or recommend therapy. It is an informational resource designed as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugs.com does not assume any responsibility for any aspect of healthcare administered with the aid of this information. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 1996-2018 Drugs.com. Revision Date: 2017-11-15 21:03:48